ABBOTT LABS/ US0028241000 /
5/6/2024 8:12:07 AM | Chg. 0.00 | Volume | Bid2:14:31 PM | Ask2:14:31 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
98.40EUR | 0.00% | 0 Turnover: 0.00 |
98.60Bid Size: 111 | 99.40Ask Size: 100 | 171.17 bill.EUR | - | - |
GlobeNewswire
3/25
Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer
GlobeNewswire
3/15
Attention Reckitt Benckiser Group investors: Portnoy Law Firm Announces Investigation into Reckitt B...
GlobeNewswire
11/14/2023
NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports In...
GlobeNewswire
10/19/2023
Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer
GlobeNewswire
10/10/2023
Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO
GlobeNewswire
10/2/2023
Apnimed Adds Independent Director Paul Fonteyne, MS, MBA to Board of Directors